Yuta Yamasaki
Overview
Explore the profile of Yuta Yamasaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Keya J, Akter M, Yamasaki Y, Kageyama Y, Sada K, Kuzuya A, et al.
Small
. 2024 Dec;
:e2408364.
PMID: 39716855
The assembly of biological systems forms nonequilibrium patterns with different functionalities through molecular-level communication via stepwise sequential interaction and activation. The mimicking of this molecular signaling offers extensive opportunities to...
2.
Sharma T, Kashihara S, Yamasaki Y, Ozaki Y, Takahashi I, Sato H
J Phys Chem B
. 2023 Aug;
127(35):7602-7614.
PMID: 37611194
Utilizing X-ray reflectivity and infrared reflection absorption spectroscopy (IR-RAS), we have investigated the thermal expansion and contraction of ultrathin polyvinylphenol (PVPh) films supported on a silicon (100) substrate capped with...
3.
Irie K, Nanjo S, Hata A, Yamasaki Y, Okada Y, Katakami N, et al.
Bioanalysis
. 2019 May;
11(9):847-854.
PMID: 31084202
The transitivity of osimertinib to cerebrospinal fluid (CSF) is of clinical concern. A quantitative LC-MS/MS method for the determination of osimertinib in human plasma and CSF was developed to evaluate...
4.
Irie K, Okada A, Yamasaki Y, Kokan C, Hata A, Kaji R, et al.
Ther Drug Monit
. 2018 Jul;
40(6):716-724.
PMID: 30048380
Background: Nivolumab is a fully humanized IgG4 monoclonal antibody that targets the programmed death-1 (PD-1) receptor, disrupting PD-1-mediated signaling and restoring antitumor immunity. The objective of this study was to...
5.
Irie K, Shobu S, Hiratsuji S, Yamasaki Y, Nanjo S, Kokan C, et al.
J Chromatogr B Analyt Technol Biomed Life Sci
. 2018 Apr;
1087-1088:1-5.
PMID: 29689441
A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated for the quantification of gefitinib in dried blood spots (DBSs). Gefitinib was extracted with methanol from DBS of 3 ...